| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/17/2003 | CN1121228C Medicine for treating cardiac and cerebral vascular disease and hypertension and its preparation process |
| 09/17/2003 | CN1121224C Pharmaceutical composition comprising compound having anti Xa activity and platelet aggregation antagonist compound |
| 09/16/2003 | US6620919 Lipoxin compounds and their use in treating cell proliferative disorders |
| 09/16/2003 | US6620915 Monoclonal antibodies specific for integrin α-d subunit |
| 09/16/2003 | US6620853 Methods and compositions for prevention and treatment of restenosis with non-steroidal anti-inflammatory drugs |
| 09/16/2003 | US6620851 Methods for the treatment of neuropathic pain and other disorders using R(−)-ketoprofen |
| 09/16/2003 | US6620849 Bicyclic sulfanimde compounds useful for the treatment of cardiac arrhythmias |
| 09/16/2003 | US6620845 For therapy and prophylaxis of neurological diseases |
| 09/16/2003 | US6620840 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 09/16/2003 | US6620839 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 09/16/2003 | US6620835 Method of inhibiting matrix metalloproteinases |
| 09/16/2003 | US6620832 Substituted ureas |
| 09/16/2003 | US6620831 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation |
| 09/16/2003 | US6620820 Inhibitors of bone reabsorption and antagonists of vitronectin receptors |
| 09/16/2003 | US6620814 Mixture with partially neutralized pH-dependent binder; antiarrhythmia agents; cardiovascular disorders, myocardium infarction |
| 09/16/2003 | US6620811 Isonicotin- and nicotinamide derivatives of benzothiazoles |
| 09/16/2003 | US6620810 4-thioxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents |
| 09/16/2003 | US6620809 Substituted (dihydro)benzoxazine and (dihydro)benzothiazine compounds |
| 09/16/2003 | US6620806 Estrogen agonist/antagonist to prevente myocardial infarction or stroke, maintaining or improving vascular reactivity, treat renal failure, peripheral arterial occlusive disease, coronary artery disease, or raynaud's phenomenon |
| 09/16/2003 | US6620789 Compounds are provided that inhibit the interaction of an IGF with any one of its binding proteins and not to a human IGF receptor. These IGF agonist compounds, which include peptides, are useful to increase serum and tissue levels of active IGFs |
| 09/16/2003 | US6620784 Uses of VEGF-E |
| 09/16/2003 | US6620782 compounds having Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or |
| 09/16/2003 | US6620778 Cysteine/glycine rich peptides |
| 09/16/2003 | US6620439 Chrono delivery formulations and method of use thereof |
| 09/16/2003 | CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 09/16/2003 | CA2238736C Novel a1 adenosine receptor agonists and antagonists |
| 09/16/2003 | CA2232116C Novel n-aryl piperidine compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/16/2003 | CA2215695C .beta.-sheet mimetics and use thereof as protease inhibitors |
| 09/16/2003 | CA2130577C Combinations of ace inhibitors and diuretics |
| 09/16/2003 | CA2078759C Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
| 09/16/2003 | CA2019404C 11 beta-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
| 09/15/2003 | CA2421490A1 Medicament against thrombotic diseases |
| 09/12/2003 | WO2003075015A2 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 09/12/2003 | WO2003074711A1 Expression cassette for persistence of expression of a gene of interest in muscle cells |
| 09/12/2003 | WO2003074694A1 Adipocyte differentiation-associated genes and proteins |
| 09/12/2003 | WO2003074684A1 Cells capable of differentiating into myocardium-like cells |
| 09/12/2003 | WO2003074564A1 Novel hemepeptide |
| 09/12/2003 | WO2003074560A2 Critical hypoxia-inducible factor-1alpha residues, products and methods related thereto |
| 09/12/2003 | WO2003074559A1 Falp proteins |
| 09/12/2003 | WO2003074532A1 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase |
| 09/12/2003 | WO2003074531A1 Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity |
| 09/12/2003 | WO2003074520A1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain |
| 09/12/2003 | WO2003074517A1 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 09/12/2003 | WO2003074516A1 Phthalimide carboxylic acid derivatives |
| 09/12/2003 | WO2003074515A1 Diamino-pyrimidines and their use as angiogenesis inhibitors |
| 09/12/2003 | WO2003074513A2 Indole amide derivatives and their use as glycogen phosphorylase inhibitors |
| 09/12/2003 | WO2003074512A1 Isoquinoline derivatives |
| 09/12/2003 | WO2003074508A1 Compounds and methods of treating cell proliferative diseases |
| 09/12/2003 | WO2003074495A1 Hppars activators |
| 09/12/2003 | WO2003074489A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase |
| 09/12/2003 | WO2003074485A2 Indole-amide derivatives and their use as glycogen phosphorylase inhibitors |
| 09/12/2003 | WO2003074484A1 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity |
| 09/12/2003 | WO2003074483A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| 09/12/2003 | WO2003074479A1 Semicarbazide derivatives and their use as antithrombotics |
| 09/12/2003 | WO2003074469A1 Novel cinnamate salts, method for production and use thereof as medicaments |
| 09/12/2003 | WO2003074080A1 Treatment of central nervous system damage |
| 09/12/2003 | WO2003074078A2 Cg3842 homologous proteins involved in the regulation of energy homeostasis |
| 09/12/2003 | WO2003074073A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 09/12/2003 | WO2003074072A1 Methods and compositions for the treatment of ischemia |
| 09/12/2003 | WO2003074057A1 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident |
| 09/12/2003 | WO2003074052A1 Thiazole and oxazole derivatives that modulate ppar activity |
| 09/12/2003 | WO2003074051A1 Substituted thiazoles and oxazoles that modulate ppar activity |
| 09/12/2003 | WO2003074050A1 Thiazole and oxazole derivatives which modulate ppar activity |
| 09/12/2003 | WO2003074043A1 Body temperature elevating agents |
| 09/12/2003 | WO2003074039A1 Compositions for preventing hypertension |
| 09/12/2003 | WO2003074008A2 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 09/12/2003 | WO2003073987A2 Compounds that modulate the activity of ptp-1b and tc-ptp |
| 09/12/2003 | WO2003073986A2 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 09/12/2003 | WO2003051333B1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
| 09/12/2003 | WO2003041684A3 Injectable depot compositions and uses thereof |
| 09/12/2003 | WO2003037268A3 Hepta-, octa- and nonapeptides having antiangiogenic activity |
| 09/12/2003 | WO2003034995A3 Integrin targeting compounds |
| 09/12/2003 | WO2003034987A3 Androgen receptor modulators and methods of use thereof |
| 09/12/2003 | WO2003032969A3 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications |
| 09/12/2003 | WO2003003017A3 Use of transcription factor nak-1 or genes regulated by transcription factor nak-1 for the diagnosis and/or therapy of inflammatory and malignant diseases |
| 09/12/2003 | WO2002080979A3 Conjugate of hydroxyalkyl starch and an active agent |
| 09/12/2003 | WO2002062205A3 Methods for diagnosing and treating heart disease |
| 09/12/2003 | WO2002060871A3 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 09/12/2003 | WO2002058732B1 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 09/12/2003 | WO2002043717A3 Treatment of varicose veins |
| 09/12/2003 | WO2002040486A3 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS |
| 09/12/2003 | WO2002038794A3 Cardiovascular disease diagnostic and therapeutic targets |
| 09/12/2003 | WO2002032961A8 Novel polypeptides and nucleic acids encoding same |
| 09/12/2003 | WO2002009683A3 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 09/12/2003 | WO2001095785A3 Modulation of immune response and methods based thereon |
| 09/12/2003 | WO2001090064A3 COMPOSITION AND METHOD CONTAINING PRODUCTS EXTRACTED FROM COMMIPHORA Sp. FOR PREVENTION AND TREATMENT OF ABNORMAL CELL GROWTH AND PROLIFERATION IN INFLAMMATION, NEOPLASIA AND CARDIOVASCULAR DISEASE |
| 09/12/2003 | CA2481307A1 Phthalimide carboxylic acid derivatives |
| 09/12/2003 | CA2478618A1 Isoquinoline derivatives |
| 09/12/2003 | CA2478528A1 Semicarbazide derivatives and the use thereof as antithrombotics |
| 09/12/2003 | CA2478520A1 Thiazole and oxazole derivatives which modulate ppar activity |
| 09/12/2003 | CA2478164A1 Substituted thiazoles and oxazoles that modulate ppar activity |
| 09/12/2003 | CA2478133A1 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident |
| 09/12/2003 | CA2478042A1 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 09/12/2003 | CA2477969A1 Falp proteins |
| 09/12/2003 | CA2477900A1 Composition for preventing hypertension |
| 09/12/2003 | CA2477874A1 Expression cassette for persistence of expression of a gene of interest in muscle cells |
| 09/12/2003 | CA2477717A1 Indolamid derivatives which possess glycogen phosphorylase inhibitory activity |
| 09/12/2003 | CA2477715A1 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
| 09/12/2003 | CA2477667A1 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase |
| 09/12/2003 | CA2477662A1 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |